Skip to content
2000
Volume 22, Issue 8
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

An urgent need exists for a rapid, cost-effective, facile, and reliable nucleic acid assay for mass screening to control and prevent the spread of emerging pandemic diseases. This urgent need is not fully met by current diagnostic tools. In this review, we summarize the current state-of-the-art research in novel nucleic acid amplification and detection that could be applied to point-of-care (POC) diagnosis and mass screening of diseases. The critical technological breakthroughs will be discussed for their advantages and disadvantages. Finally, we will discuss the future challenges of developing nucleic acid-based POC diagnosis.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1570163819666220207114148
2022-03-01
2025-05-28
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1570163819666220207114148
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test